MDNews - Long Island

Introducing the Team of Specialists Stanley M. Ring, MD, FACS, Director of the Urology Program at South Nassau Communities Hospital, has cared for South Shore residents for nearly 40šyears. Dr. Ring completed his medical education at the Universidad Autónoma de Guadalajara in Mexico. He performed residency training at Nassau University Medical Center and New York Methodist Hospital. A member of multiple medical societies, Dr. Ring is board-certified in pediatric and adult urology. He holds teaching appointments at Nassau University Medical Center, where he serves as an Attending Professor of Clinical Urology, and at the Hofstra Northwell School of Medicine. Daniel S. McCally, MD, FACS, Assistant Director of the Urology Program at South Nassau Communities Hospital, is also a veteran physician of the South Shore, having joined the team in 1977. Dr. McCally received his medical degree at the New Jersey College of Medicine and Dentistry and performed his residency at Nassau University Medical Center. A board- certified urologist, Dr. McCally also serves as the Director of Urology at Nassau University Medical Center and is a Clinical Assistant Professor at Hofstra Northwell School of Medicine. Michael P. Herman, MD, Director of the Urologic Oncology Program, joined the South Nassau Communities Hospital team in July 2015 and brings special- ized expertise in urologic oncology and robotic surgery. Dr. Herman completed his undergraduate degree at Harvard University and his medical degree at the University of Texas Southwestern Medical Center. His internship in general surgery and residencies in general surgery and urology were both performed at NewYork-Presbyterian Hospital. In addition to his appointment at South Nassau Communities Hospital, Dr. Herman is an assistant attending physician at NewYork-Presbyterian/ Weill Cornell Medical Center. include erectile dysfunction and urinary incontinence, can outweigh the benefits of curing the cancer. "For many men, undetected prostate cancer would be asymptomatic and have no impact on longevity or quality of life," Dr. Herman says. "If it weren't for the elevated PSA level and subsequent biopsy, we wouldn't even realize they had cancer. Because these nonaggressive cancers pose minimal threat to their well-being, undergoing surgical treatment or radiation therapy puts them at risk for side e•ects that can be more harmful than the dis- ease itself." To determine if prostate cancer treat- ment is necessary, physicians consider a variety of factors, including age and cancer stage. Prostate cancer treatment may be indicated for men with a life expectancy of over 10 years. However, early-stage cancer that develops in elderly men may be treated like a chronic disease with active surveillance, which typically involves monitoring disease progression via biannual PSA and digital rectal screenings. Stanley M. Ring, MD, FACS, Director of the Urology Program, and Buelah Lisa Powell, FNP-BC, Surgery, discuss treatment options with a prostate cancer patient. Dr. Herman, seated at the da Vinci Si surgical console, prepares for a robotic prostatectomy. " South Nassau Communities Hospital offers a broad spectrum of urologic care, treating the simplest to the most complex disorders. Because our team includes younger and older urologists, patients can also take advantage of the expertise of physicians skilled in both conventional and new techniques. The confluence of the old and the new is a great benefit for patients." STANLEY M. RING, MD, FACS, DIRECTOR OF THE UROLOGY PROGRAM AT SOUTH NASSAU COMMUNITIES HOSPITAL 0 8 C O V E R F E A T U R E 0 8

• Cover